A team of Japanese researchers has made a significant breakthrough by successfully removing the extra chromosome responsible for Down syndrome in cultured human cells.
This advancement marks an important step forward in genetic research focused on understanding and potentially treating the condition.
Down syndrome is caused by the presence of a third copy of chromosome 21, known as trisomy 21. Using advanced gene-editing technology, the scientists were able to selectively eliminate the extra chromosome from cells taken from individuals with Down syndrome.
The corrected cells then showed gene activity patterns much closer to those of typical cells, which have two copies of chromosome 21.
While this achievement is currently limited to laboratory cell cultures, it opens new possibilities for future therapies aimed at mitigating or reversing some effects of Down syndrome.
However, experts caution that applying these techniques safely and effectively in living patients remains a complex challenge, and clinical applications are still far off.
This research demonstrates rapid progress in chromosome engineering and gene therapy, offering renewed hope for tackling genetic disorders through innovative medical science.
